| Literature DB >> 33131220 |
Yoon-Kyoung Sung1, Hyoungyoung Kim1, Sung Joo Cha1, Sae-Hyung Kim2, Mwidimi Ndosi3, Soo-Kyung Cho1.
Abstract
BACKGROUND/AIMS: This study was performed to undertake cross-cultural adaptation and validation of the Educational Needs Assessment Tool (ENAT) in rheumatoid arthritis (RA) for use in Korea.Entities:
Keywords: Arthritis, rheumatoid; Needs assessment; Patient education as topic; Rasch analysis; Validation studies as topic
Mesh:
Year: 2020 PMID: 33131220 PMCID: PMC8273824 DOI: 10.3904/kjim.2019.422
Source DB: PubMed Journal: Korean J Intern Med ISSN: 1226-3303 Impact factor: 2.884
Participants’ characteristics (n = 123)
| Characteristic | Value |
|---|---|
| Demographics | |
| Age, yr | 46.5 ± 12.2 |
| Female | 100 (81.3) |
| Disease duration, yr | 5.0 ± 6.0 |
| Education duration, yr | 13.0 ± 3.0 |
| Employed | 73 (59.3) |
| Regular exercise | 47 (38.2) |
| Smoking (n = 122) | |
| Non-smoker | 89 (73.0) |
| Ever smoker | 17 (13.9) |
| Current smoker | 16 (13.1) |
| Disease status | |
| DAS28-ESR | 3.5 ± 1.5 |
| DAS28-CRP | 3.2 ± 1.3 |
| Patient GA VAS, mm | 41.2 ± 23.7 |
| Physician GA VAS, mm | 19.9 ± 19.9 |
| Pain VAS, mm | 36.7 ± 27.0 |
| Sleep disturbance VAS, mm | 22.8 ± 27.8 |
| Fatigue VAS, mm | 29.6 ± 28.4 |
| HAQ-DI | 0.6 ± 0.6 |
| EQ-5D | 0.8 ± 0.1 |
| Medication | |
| Methotrexate | 100 (81.3) |
| Corticosteroid | 98 (79.7) |
| Corticosteroid dose, mg/day | 2.7 ± 0.8 |
| Biologic DMARDs | 15 (12.2) |
Values are presented as mean ± standard deviation or number (%).
DAS28-ESR, disease activity score in 28 joints with erythrocyte sedimentation rate; DAS28-CRP, disease activity score in 28 joints with C-reactive protein; GA, global health assessment; VAS, visual analogue scale; HAQ-DI, health assessment questionnaires-disability index; EQ-5D, Euro-Quality of Life-5 Dimension; DMARD, disease-modifying antirheumatic drug.
Fit statistics for the Korean ENAT subscales
| Variable | Item | Infit | Outfit | PTMEA CORR | ||
|---|---|---|---|---|---|---|
| MNSQ | ZSTD | MNSQ | ZSTD | |||
| Subscale | ||||||
| Pain | 1 | 1.03 | 0.30 | 1.10 | 0.60 | 0.50 |
| 2 | 1.64 | 4.50 | 2.23 | 6.90 | 0.42 | |
| 3 | 1.46 | 3.30 | 1.78 | 4.50 | 0.50 | |
| 4 | 0.92 | −0.70 | 0.89 | −0.80 | 0.65 | |
| 5 | 1.10 | 0.80 | 1.16 | 1.00 | 0.57 | |
| 6 | 1.51 | 3.70 | 1.61 | 3.90 | 0.54 | |
| Movement | 7 | 1.05 | 0.50 | 1.08 | 0.70 | 0.68 |
| 8 | 0.97 | −0.20 | 0.98 | −0.10 | 0.70 | |
| 9 | 0.83 | −1.50 | 0.77 | −1.80 | 0.73 | |
| 10 | 0.87 | −1.00 | 0.79 | −1.20 | 0.64 | |
| 11 | 1.08 | 0.60 | 1.03 | 0.30 | 0.58 | |
| Feelings | 12 | 0.71 | −2.30 | 0.70 | −1.90 | 0.66 |
| 13 | 0.85 | −1.10 | 0.78 | −1.40 | 0.66 | |
| 14 | 0.81 | −1.50 | 0.82 | −1.20 | 0.66 | |
| 15 | 0.95 | −0.40 | 0.91 | −0.60 | 0.67 | |
| Disease process | 16 | 0.86 | −0.90 | 0.80 | −1.00 | 0.59 |
| 17 | 0.88 | −0.80 | 0.87 | −0.60 | 0.58 | |
| 18 | 0.90 | −0.60 | 0.94 | −0.20 | 0.56 | |
| 19 | 1.02 | 0.20 | 0.73 | −1.20 | 0.57 | |
| 20 | 0.90 | −0.60 | 0.74 | −1.30 | 0.58 | |
| 21 | 1.04 | 0.30 | 0.95 | −0.30 | 0.63 | |
| 22 | 0.86 | −0.90 | 0.73 | −1.30 | 0.57 | |
| Treatments | 23 | 0.91 | −0.60 | 0.77 | −1.20 | 0.60 |
| 24 | 0.99 | 0.00 | 0.84 | −0.80 | 0.61 | |
| 25 | 0.89 | −0.70 | 0.85 | −0.60 | 0.55 | |
| 26 | 0.97 | −0.10 | 0.82 | −0.90 | 0.59 | |
| 27 | 0.85 | −1.00 | 0.74 | −1.60 | 0.64 | |
| 28 | 1.25 | 1.70 | 1.17 | 1.00 | 0.54 | |
| 29 | 1.11 | 0.90 | 1.06 | 0.50 | 0.65 | |
| Self-help | 30 | 2.08 | 6.80 | 2.32 | 8.20 | 0.44 |
| 31 | 1.08 | 0.70 | 1.31 | 1.90 | 0.56 | |
| 32 | 0.76 | −1.90 | 0.76 | −1.50 | 0.67 | |
| 33 | 0.87 | −1.00 | 0.83 | −1.00 | 0.63 | |
| 34 | 0.96 | −0.30 | 0.91 | −0.50 | 0.64 | |
| 35 | 0.96 | −0.20 | 0.89 | −0.70 | 0.64 | |
| Support | 36 | 0.85 | −1.10 | 0.79 | −1.40 | 0.67 |
| 37 | 1.18 | 1.50 | 1.39 | 2.50 | 0.60 | |
| 38 | 1.31 | 2.40 | 1.48 | 3.20 | 0.60 | |
| 39 | 0.72 | −2.30 | 0.69 | −2.20 | 0.70 | |
| Domain | ||||||
| Pain | 1.31 | 2.30 | 1.40 | 2.80 | 0.75 | |
| Movement | 1.00 | 0.10 | 1.01 | 0.10 | 0.85 | |
| Feelings | 0.77 | −1.90 | 0.80 | −1.60 | 0.84 | |
| Disease process | 1.27 | 2.00 | 1.15 | 1.00 | 0.84 | |
| Treatments | 1.30 | 2.20 | 1.21 | 1.40 | 0.85 | |
| Self-help | 1.05 | 0.50 | 1.08 | 0.70 | 0.84 | |
| Support | 0.75 | −2.10 | 0.75 | −2.10 | 0.83 | |
MNSQ between ≥ 0.50 and ≤ 1.50 suggest fit to the model.
ENAT, Educational Needs Assessment Tool; MNSQ, mean-square; ZSTD, z-standardized; PTMEA CORR, point-measure correlation.
Internal consistency and test-retest results
| Variable | Score | Internal consistency (Cronbach’s alpha) | ICC (95% CI) | |||||
|---|---|---|---|---|---|---|---|---|
| Q1 | Median | Q3 | Range | Floor effect, % | Ceiling effect, % | |||
| Pain | 12 | 15 | 18 | 3–24 | 0 | 0.81 | 0.78 | 0.59 (0.45−0.70) |
| Movement | 9 | 13 | 16 | 0–20 | 0.81 | 13.82 | 0.89 | 0.59 (0.45−0.70) |
| Feeling | 9 | 12 | 15 | 0–16 | 3.25 | 21.95 | 0.90 | 0.75 (0.65−0.82) |
| Disease process | 21 | 24 | 27 | 2–28 | 0 | 24.39 | 0.92 | 0.65 (0.53−0.75) |
| Treatment | 19 | 22 | 27 | 5–28 | 0 | 21.14 | 0.90 | 0.60 (0.46−0.71) |
| Self-help | 12 | 17 | 20 | 2–24 | 0 | 5.69 | 0.86 | 0.72 (0.62−0.80) |
| Support | 7 | 11 | 13 | 0–16 | 1.63 | 13.82 | 0.83 | 0.72 (0.62−0.80) |
| Total score | 89 | 113 | 129 | 28–156 | 0 | 0.81 | 0.92 | 0.79 (0.71−0.85) |
ICC, intraclass correlation coefficient; CI, confidence interval.
ENAT in Korean RA patients
| Variable | Total (n = 123) | Male | Female | ||||
|---|---|---|---|---|---|---|---|
| Mean ± SD | Mean, %[ | Mean ± SD | Mean, %[ | Mean ± SD | Mean, %[ | ||
| Pain | 14.8 ± 4.8 | 62 | 14.1 ± 4.6 | 59 | 14.9 ± 4.9 | 62 | 0.48 |
| Movement | 12.6 ± 5.2 | 63 | 11.1 ± 5.2 | 55 | 13.0 ± 5.2 | 65 | 0.12 |
| Feeling | 11.2 ± 4.1 | 70 | 9.3 ± 4.3 | 58 | 11.7 ± 4.0 | 73 | 0.01 |
| Disease process | 22.8 ± 5.5 | 81 | 23.4 ± 4.2 | 84 | 22.6 ± 5.8 | 81 | 0.56 |
| Treatment | 21.6 ± 5.8 | 77 | 21.2 ± 6.1 | 76 | 21.7 ± 5.8 | 77 | 0.71 |
| Self-help | 16.0 ± 5.3 | 67 | 15.0 ± 5.0 | 63 | 16.2 ± 5.4 | 68 | 0.34 |
| Support | 10.2 ± 4.0 | 63 | 8.8 ± 3.8 | 55 | 10.5 ± 4.0 | 65 | 0.07 |
| Total score | 109.1 ± 28.9 | 70 | 102.9 ± 26.0 | 66 | 110.6 ± 29.5 | 71 | 0.26 |
ENAT, Educational Needs Assessment Tool; RA, rheumatoid arthritis; SD, standard deviation.
Percentage of maximum possible score (for each domain score or total score).